Biotechnology News

PLYMOUTH MEETING, Pa., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report third quarter 2026 financial results on Wednesday,...

Parkinson’s patients elevated baseline inflammation demonstrated statistically significant improvements in both motor and non-motor symptoms with Bezisterim compared to placebo.  CARSON CITY, Nev.,...

BURLINGAME, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Biomolecular Holdings LLC, a privately held biotechnology company advancing next-generation antibody architectures, today announced that the...

CPTx to present new preclinical data for its in vivo CAR T cell therapies at ESGCT 2026.

Medicovestor announces FDA Fast Track designation for MC001, its first-in-class chemoimmunotherapy ADC for pancreatic cancer.

Expands Kane Biotech’s commercial footprint and access to the revyve® product line across Canada WINNIPEG, Manitoba, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”,...

PolarityBio® announced it received the Highest Scoring Abstract Award in the Clinical Research category at the Symposium on Advanced Wound Care Fall 2026.

YOL104-2 is a bioengineered, trivalent, multifunctional peptibody incorporating a core interferon-mimetic with the potential to be a first-in-class therapy for Ocular Surface Squamous Neoplasia (OSSN)...

MAINZ, Germany, October 20, 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2026 on Tuesday, November 3, 2026....

MAINZ, Deutschland, 20. Oktober 2026 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird am Dienstag, den 3. November 2026, die Ergebnisse für das dritte Quartal...